AOD-9604 research monograph — the hGH fragment and the obesity-trial record

AOD-9604 is widely marketed as a "fat-loss peptide", which makes an honest read
of its actual trial record especially important.

Chemical identity & structure.
AOD-9604 is a synthetic peptide based on a fragment of human growth hormone —
specifically the C-terminal region (residues 176–191) of the hGH molecule, with
a modification (an added tyrosine) to the fragment. It represents only a small
piece of the full growth-hormone protein.

Mechanism of action.
AOD-9604 was designed on the hypothesis that the fat-metabolism-related activity
of growth hormone is localized to this C-terminal fragment, so the fragment
could influence lipolysis (fat breakdown) without the broader effects — and
glucose-metabolism drawbacks — of full growth hormone. The mechanism in humans
is not well established and should be read as a hypothesis that the trial data
did not strongly confirm.

Key research findings.
This is the key section. AOD-9604 was advanced into human clinical trials for
obesity. The published clinical-trial record is not a success story: the
trials did not demonstrate the hoped-for clinically meaningful weight-loss
benefit. Marketing claims of AOD-9604 as an effective fat-loss compound run well
ahead of what those trials showed.

The research / citation base.
AOD-9604 is not approved as a weight-loss drug. It was evaluated in human
obesity trials that did not meet their efficacy goals. It has been reviewed in
some jurisdictions in other contexts (for example, food-ingredient or
topical-research contexts). Anyone presenting AOD-9604 as a proven fat-loss
therapy is misrepresenting the evidence.

Research protocols in the literature.
Obesity trials used oral and subcutaneous routes. Research-grade material is a
lyophilized powder for reconstitution.

Quality & sourcing notes.
A batch-specific COA with mass-spectrometry identity and HPLC purity is the
minimum bar. The harder issue here is not purity but efficacy expectations — no
COA can substantiate the marketing claims.

*Research-use note: Educational summary of published research. AOD-9604 is not an
approved weight-loss drug; this is research context only and not medical advice.*